ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
US Tech 100
20,266.40
0.33%
Dow Jones
44,296.51
0.97%
Brent Oil
74.65
0.00%
Bitcoin
98,594.55
-0.44%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Biogen Inc (1BIIB) Quote

Biogen Inc

Biogen Inc (1BIIB)

BIT
146.95
0.00
(0.00%)
Closed November 23 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
146.95
Bid
152.05
Ask
152.70
Volume
0.00
0.00 Day's Range 0.00
146.95 52 Week Range 244.60
Market Cap
21.413B
Previous Close
146.95
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
47
Shares Outstanding
145,719,340
Dividend Yield
-
PE Ratio
19.82
Earnings Per Share (EPS)
7.97
Revenue
9.84B
Net Profit
1.16B

About Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.biogen.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Italian Stock Exchange with ticker 1BIIB. The last closing price for Biogen was 146.95 €. Over the last year, Biogen shares have traded in a share price range of 146.95 € to 244.60 €.

Biogen currently has 145,719,340 shares outstanding. The market capitalization of Biogen is 21.41 € billion. Biogen has a price to earnings ratio (PE ratio) of 19.82.

Ask ADVFN Intelligence (AI)

1BIIB Latest News

More News

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

November 19 2024
UK Regulatory

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

November 14 2024
UK Regulatory

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

October 30 2024
UK Regulatory

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

October 29 2024
UK Regulatory

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

October 29 2024
UK Regulatory

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

October 28 2024
UK Regulatory

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 The detailed study results confirmed interim...

October 26 2024
UK Regulatory

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB...

October 24 2024
UK Regulatory

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024 Late breaker oral presentation to feature final results of the Phase 2 IGNAZ study...

October 22 2024
UK Regulatory

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients Designation is based on data from the...

October 09 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-11.8-7.43307086614158.75160.3146.9535153.20714286DE
4-23.45-13.7617370892170.4173.4146.9541163.54971591DE
12-39-20.9733799408185.95185.95146.9547169.50563595DE
26-63.05-30.0238095238210220.7146.9539183.0875986DE
52-68.65-31.8413729128215.6244.6146.9534193.42657213DE
156-68.65-31.8413729128215.6244.6146.9534193.42657213DE
260-68.65-31.8413729128215.6244.6146.9534193.42657213DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WTFINTrevi Finanziaria Industriale Spa
1.30 €
(28.71%)
31
PLCPlc Spa
1.775 €
(18.73%)
167.84k
1SMCISuper Micro Computer Inc
31.53 €
(16.35%)
28.42k
1MRNAModerna Inc
40.565 €
(15.24%)
6.47k
COSMOFarmacosmo spa
0.43 €
(12.86%)
93.07k
WISC24Integrated System Credit Consulting Fintech Spa
0.0035 €
(-49.28%)
50k
ECNLAAAquafil SpA
0.039 €
(-18.07%)
314.46k
1SYMSymrise AG
105.00 €
(-17.13%)
62
WIVN26iVision Tech SpA
0.25 €
(-16.67%)
6.51k
1EVTEvotec SE
8.26 €
(-16.57%)
7.02k
TITTelecom Italia SpA
0.2317 €
(0.78%)
106.93M
ISPIntesa Sanpaolo Spa
3.631 €
(-1.00%)
95.09M
SPMSaipem Spa
2.399 €
(1.18%)
56.12M
ENELEnel Spa
6.73 €
(2.28%)
29.44M
RNRisanamento
0.0245 €
(4.70%)
20.21M

Discussion

View Full Feed
thistraderknowsall thistraderknowsall 9 minutes ago
VTHO VeThor crypto!!!!Surges over .01 tonight on buyo to $1+ stay tuned!
236T568 236T568 10 minutes ago
Putin AI? Strange body movements spark theories of fake Vlad leading nation

A new video of Vladimir Putin addressing Russia has raised eyebrows due to his odd body movements and gesticulations.

https://www.the-express.com/news/world-news/155583/vladimir-putin-ai-video
Nrdc92 Nrdc92 19 minutes ago
Absolutely true, Vein. When you compare LWLG to Lm, you see that Lm has all the things LWLG does not: strategic partnerships, market buzz, third party investments, massive capital raises. LWLG has been dicking around for over twenty years, moving from one incompetent leadership team to the next, wit
LWLG
dinogreeves dinogreeves 20 minutes ago
Thank you.
SMCI
dinogreeves dinogreeves 21 minutes ago
I am extremely convinced that VCNX will hit triple dollars in 18 months or less. Just give me buyout at 500 million dollars $195 dollars or a billion dollars for twice more. Outstanding science, this is one of the best of best breed in this sector.
VCNX
dinogreeves dinogreeves 25 minutes ago
Daily fluctuations doesn't tickle me, my last lesson was to know what you hold and reap the rewards. Just five months ago, I scored a tad above 5 grand in one day trade and I bought around 65 dollars, look at the price now. SMCI will do the same. Just give me Nasdaq extension this runs 100% in 2-
CAVA SEZL SMCI
LEFTY1182 LEFTY1182 29 minutes ago
Hopefully it is because they want more shares. This thing could run to $4.00 if they have positive results and they get this trading again.
RSPI
creede creede 41 minutes ago
I said it several years ago and I will say it again — sooner or later DOGECOIN will be #1 in Marketcap size. 
DOGEUSD
BornAgain BornAgain 43 minutes ago
https://chqgov.com/county-executive/news/electrovaya-secures-508-million-exim-loan-jamestown-facility
ELVA
Kreator Kreator 44 minutes ago
Do you want to know what is Brutal, your constant crying and whining.

Hello whining copymachine with no news, i'm shocked, brutal, we have been misled, simply painful, when does the pain stop, etc etc, day in day out.

@vein get lost you ridiculous whining copymachine,
LWLG
Jackxkr Jackxkr 46 minutes ago
I'm now 63 years of age. It does for whatever reason give me hope that I may see this through to be successful given others ages. It seems like myself there are a lot of others that are " seniors " . How old are we if u dare to post your ages .?
I also think Tyson was paid off , he's old b
NWBO
frankyahoo frankyahoo 48 minutes ago
Wow.  Nice pump.
ADAUSD
caycehopeful caycehopeful 53 minutes ago
Q quarterly--I'm sure Big D still has some surprises for Josh and Angus!..............not the good kind.
https://www.otcmarkets.com/otcapi/company/financial-report/417479/content
ATWT
Steady_T Steady_T 56 minutes ago
That embedding worked for me. My Pillow guy for head inquisitor at Gitmo. Play My pillow commercials 24/7 till they break. No need for waterboarding.
in99flyers in99flyers 57 minutes ago
Shiba has outperformed both XRP and ADA on the 1 year chart. Stop being a prisoner of the moment and relax and know what you own
SHIBUSD
Jack Torrance Jack Torrance 59 minutes ago
Yeah, the comparison to the dotcom bubble is so stupid. This is a real company with real, actual, groundbreaking technology. And they are under-promising and over-delivering, which is so rare and refreshing for start ups these days.
IONQ
Steady_T Steady_T 60 minutes ago
Where did you get that silly idea?
kittycattttt kittycattttt 1 hour ago
:-)
DOGEUSD
Researchfyi Researchfyi 1 hour ago
Does this raise more questions…

https://www.investopedia.com/terms/s/sec-form-s-1.asp
LQMT
Preciouslife1 Preciouslife1 1 hour ago
https://www.facebook.com/share/r/1AqQRy2Hdm/?mibextid=6GsUZ4
BubbaInSC BubbaInSC 1 hour ago
FUNN not so Fun

Wow. Guess I’m not surprised at downturn.

End of year selling for tax write off of losses.

For those who have money to lose, maybe someone can pick up stock in 0.001s
FUNN
jason sundar jason sundar 1 hour ago
Another up day with volume 
BARUF
HyGro HyGro 1 hour ago
Clearly NOT. NWBO gets paid for patients on com[passionate care programs. Advent's rate card for DCVax-L compassionate care is $250K. And NWBO has not shown any material revenue so clearly they are not treating many patients as all -- whether UK or U.S.

Once again, you seem to ig
NWBO
johnydollar johnydollar 1 hour ago
They probably read 📚 them as they sh!t bricks.........

It's not fun to sh!t bricks.........

Oh do they miss revocation........

Oh well........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆
DBMM
littlejohn littlejohn 1 hour ago
SMCI may start trying on $38 on Monday...

that is steady resistance going back to

being set up as support back in early

September on lows on trading days...

https://www.barchart.com/stocks/quotes/SMCI/interactive-chart

Buyers
SMCI

Your Recent History

BIT
1BIIB
Biogen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved